Migalastat API Manufacturers
compare suppliers & get competitive offers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Migalastat API ?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Migalastat. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Migalastat
- DrugBank number:
- DB05018
- Unique Ingredient Identifier:
- C4XNY919FW
About Migalastat
More information about this product: Fabry disease is a rare, progressive genetic disorder characterized by a defective GLA gene that causes a deficiency in the enzyme alpha-Galactosidase A (alpha-Gal A) This enzyme is responsible for breaking down glycosphingolipid substrate that, when deficient in patients with Fabry disease, builds up in the blood vessels, the kidneys, the nerves, the heart, and other organs In the USA, it is estimated that more than000 people are living with Fabry disease, and an estimated more than 50 percent of these diagnosed patients are currently untreated Migalastat (approved and sold under Amicus Therapeutics' brand name Galafold) is subsequently an oral pharmacological chaperone of alpha-Gal A for the treatment of Fabry disease in adults who have amenable GLA variants.
Check who is selling Migalastat in the overview above.
